Life Science Today

EXPLORE

Society & Culture

Health & Fitness

© 2024 PodJoint

https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/20/9c/89/209c8941-601e-2fa1-19c3-76f55af3575e/mza_14607577291171710004.jpg/600x600bb.jpg

Life Science Today

Noah Goodson, PhD

72 episodes

9 months ago

This week, I have an announcement to make. Find out more athttps://LifeScienceTodayPodcast.comAbout the ShowLife Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolvi...

Show more...

All content for Life Science Today is the property of Noah Goodson, PhD and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

This week, I have an announcement to make. Find out more athttps://LifeScienceTodayPodcast.comAbout the ShowLife Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolvi...

Show more...

Episodes (20/72)

Life Science Today

This week, I have an announcement to make. Find out more athttps://LifeScienceTodayPodcast.comAbout the ShowLife Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolvi...

2 years ago

4 minutes

Life Science Today

Sanofi/Takeda, UniQure & CSL, Fog Pharma, Merck + Imago

Vaccine hesitancy, the most expensive gene therapy in the world, a $178M series D, and a $1.3B buyoutFind out more athttps://LifeScienceTodayPodcast.comStory ReferencesSanofi/TakedaUniQure & CSLFog PharmaMerck + Imago About the ShowLife Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how t...

2 years ago

8 minutes

Life Science Today

Indivior + Opiant, Regeneron + CytomX, Rezo, Provention

A $145M opioid acquisition, biobucks for the holidays, a series A, and diabetes approvalsFind out more athttps://LifeScienceTodayPodcast.comStory ReferencesIndivior + OpiantRegeneron + CytomXRezoProventionAbout the ShowLife Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market r...

2 years ago

6 minutes

Life Science Today

Intellia, Regeneron, Viatris + Oyster Point

More CRISPR data, oncology wins, and a new player in ophthalmologyFind out more athttps://LifeScienceTodayPodcast.comStory ReferencesIntelliaRegeneronViatris + Oyster PointAbout the ShowLife Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Sci...

2 years ago

9 minutes

Life Science Today

Sumitovant + Myovant, Thermo Fisher + Binding Site Group, Astellas & Taysha, Agios, Vaxctye

Billion-dollar acquisitions, troubled waters for some biotech’s, and a prosperous outlook for othersFind out more athttps://LifeScienceTodayPodcast.comStory ReferencesSumitovant + MyovantThermo Fisher + Binding Site GroupAstellas & TayshaAgiosVaxctyeAbout the ShowLife Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capit...

3 years ago

8 minutes

Life Science Today

FDA, AbbVie + DJS, Roche + Hookipa, Kyverna

Some statistically significant guidance, seed to acquisition, some biobucks, and the CART of the future. Find out more athttps://LifeScienceTodayPodcast.comStory References FDAAbbVie + DJSRoche + HookipaKyvernaAbout the ShowLife Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock mar...

3 years ago

8 minutes

Life Science Today

DICE, Odyssey, Fred Hutch, Merck (MSD)

One biotech is on a roll, another is moving quickly, Amazon money for cancer, and some clinical development news Find out more athttps://LifeScienceTodayPodcast.comStory ReferencesDICEOdysseyFred HutchMerck (MSD), Merck Story 2About the ShowLife Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and ...

3 years ago

7 minutes

Life Science Today

Nested, Cellarity, Replimune, Estrella

Biotech’s with a series A, a series C, some debt financing, and there is even a Biopharma heading for a SPACFind out more athttps://LifeScienceTodayPodcast.comStory ReferencesNested TherapeuticsCellarityReplimuneEstrella BiopharmaAbout the ShowLife Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, a...

3 years ago

6 minutes

Life Science Today

Eisai + Biogen, Amylyx, Sanofi + Regeneron

Major Alzheimer’s news, an ALS approval, and expanded therapies for skin conditionsFind out more athttps://LifeScienceTodayPodcast.comStory ReferencesEisai + BiogenAmylyxSanofi + RegeneronAbout the ShowLife Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotec...

3 years ago

7 minutes

Life Science Today

Alnylam, Intellia, Third Harmonic, Galvanize

A $900 raise, gene therapy news, a quick IPO, and merge three for $100MFind out more athttps://LifeScienceTodayPodcast.comStory ReferencesAlnylam, Link 2, Link 3Intellia TherapeuticsThird Harmonic BioGalvanize TherapeuticsAbout the ShowLife Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how t...

3 years ago

8 minutes

Life Science Today

Revance, Velocity + MedPharmics, Arsenal, SpringWorks

A critical aesthetics approval, site network buy-up, a very normal oncology biotech, and a busy week for one company. Find out more athttps://LifeScienceTodayPodcast.comStory ReferencesRevanceVelocity + MedPharmicsArsenalSpringWorks Link 1, Link 2, Link 3About the ShowLife Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture...

3 years ago

8 minutes

Life Science Today

Novo + Forma, Sanofi, Boehringer Ingelheim, Arcturus

A $1.1B acquisition, two FDA approvals, and grants for mRNA vaccines. Find out more athttps://LifeScienceTodayPodcast.comStory ReferencesNovo + FormaSanofiBoehringer IngelheimArcturusAbout the ShowLife Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotec...

3 years ago

6 minutes

Life Science Today

Alcon + Aerie, Novartis + Sandoz, Labcorp + RWJBH

Ophthalmology acquisitions, following the pharma trends, and a move in healthcare that is not technology related. Find out more athttps://LifeScienceTodayPodcast.comStory ReferencesAlcon + AerieNovartis + SandozLabcorp + RWJBHAbout the ShowLife Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, ...

3 years ago

6 minutes

Life Science Today

Bluebird, Endo & Pharmacies, Genentech + Jemincare, Merck + Orna

Gene therapy approval, opioid costs continue, a $650M deal, and a $3.5B RNA partnership. Find out more athttps://LifeScienceTodayPodcast.comStory ReferencesBluebirdEndo & PharmaciesGenentech + JemincareMerck + OrnaAbout the ShowLife Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the s...

3 years ago

8 minutes

Life Science Today

Pfizer, Cerevel, Abbott, AstraZeneca + Daiichi Sankyo

Spending that COVID money, brain money, Irish money, and another oncology approval. Find out more athttps://LifeScienceTodayPodcast.comStory ReferencesPfizerCerevelAbbottAstraZeneca + Daiichi SankyoAbout the ShowLife Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds...

3 years ago

6 minutes

Life Science Today

Zymergen + Ginkgo, Cassava, Teva

This week, we take a break from stories of raising capital, mergers, and FDA approvals to look at the dark side of our industry. What happens when companies fail, people lie, and good drugs make bad lives? Find out more athttps://LifeScienceTodayPodcast.comStory ReferencesZymergen + GinkgoCassavaTeva About the ShowLife Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers an...

3 years ago

7 minutes

Life Science Today

ZyVersa, Incyte, Revolution, Frontera, CAMP4, ForSight, Auron

There’s a SPAC, expanded FDA approval, more of the common, and two Bs, two AsFind out more athttps://LifeScienceTodayPodcast.comStory ReferencesZyVersaIncyteRevolutionFronteraCAMP4ForSightAuronAbout the ShowLife Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to b...

3 years ago

8 minutes

Life Science Today

Vertex + ViaCyte, Theravance, Merck + Orion, Pliant, Qiming

Cell therapy acquisition, royalties sold, biobucks-like deal, successful raise, and Chinese Venture Capital Find out more athttps://LifeScienceTodayPodcast.comStory ReferencesVertex + ViaCyteTheravance BiopharmaMerck + OrionPliant Therapeutics QimingAbout the ShowLife Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital a...

3 years ago

7 minutes

Life Science Today

Feed Drop - Interview with Dan Agroskin

FEED DROP - Clinical Research Evolved Noah and John talk with Dan Agroskin, a managing director at a leading private equity firm with a focus on the clinical research industry. We discuss how investments shape industries, what entrepreneurs should think about private equity, and the forces that drive exceptional business growth.Find Out MoreDan AgroskinClinical Research EvolvedNoah Goodson, PhDJohn ReitesKyle RickettsAbout the ShowLife Science Today is your source for stories, insights, and t...

3 years ago

37 minutes

Life Science Today

Galapagos + CellPoint + AboundBio, Radius, Ipsen + Epizyme, DEM Bio

Double acquisition, private money, affordable deals, and a surprising $70M launchFind out more athttps://LifeScienceTodayPodcast.comStory ReferencesGalapagos + CellPoint + AboundBioRadiusIpsen + EpizymeDEM Bio About the ShowLife Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock mar...

3 years ago

6 minutes